Mental Health Book

http://www.fpnotebook.com/

Mirtazapine

Aka: Mirtazapine, Remeron, Norepinephrine Antagonist Serotonin Antagonist
  1. Indications: Major Depression
    1. Unresponsive to other Antidepressants
    2. Comorbid Anxiety Disorder
    3. Comorbid Insomnia
    4. Cachectic or chronically ill patients
  2. Mechanism
    1. Tetracyclic piperazinoazepine
    2. Norepinephrine Antagonist Serotonin Antagonist
      1. Blocks Pre-synaptic Alpha 2 Adrenergic Receptors
        1. Enhances central noradrenergic activity
      2. Blocks Post-synaptic 5-HT2, 5-HT3 Serotonin Receptors
        1. Enhances central Serotoninergic activity at 5-HT-1
    3. Significant Antihistamine activity
      1. Dose dependent effect
        1. Dose 15 mg: Antihistamine effects predominate
        2. Dose 45 mg: Noradrenergic effects predominate
      2. Antihistamine Symptoms
        1. Weight gain
        2. Sedation
  3. Pharmacokinetics
    1. Half-Life: 20 to 40 hours
  4. Dosing
    1. Start: 15 mg PO qhs
    2. Effective dose: 15 to 30 mg PO qhs
  5. Efficacy: Effective in treating Major Depression
    1. Superior to Placebo
    2. As effective as Elavil, Desyrel, and Prozac
  6. Adverse Effects
    1. Somnolence (54%)
      1. Consider dosing at bedtime to improve sleep
    2. Dry Mouth (25%)
    3. Increased appetite (17%)
    4. Weight gain (12%) may be significant
    5. Dizziness (7%)
  7. Precautions
    1. Agranulocytosis (occurs in 0.1% cases)
      1. Similar Incidence to other Antidepressants
      2. Does not warrant routine CBC monitoring
    2. Do not use within 14 days of MAO inhibitor
    3. Do not use with drugs causing excessive Sedation
      1. Alcohol
      2. Benzodiazepines
  8. Advantages
    1. No cardiac effects
    2. No or minimal Orthostatic Hypotension
    3. Low incidence Antidepressant Induced Sexual Dysfunction
    4. No deaths have occurred in overdosage
  9. Drug Interactions
    1. Minimal Cytochrome P450 inhibition
  10. References
    1. Burrows (1997) Psychopharmacol 17:34S-39S [PubMed]
    2. Hartmann (1999) Am Fam Physician 59(1): 159-61 [PubMed]
    3. Majeroni (1998) J Am Board Fam Pract 11:127-39 [PubMed]
Medication Costs
mirtazapine (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
MIRTAZAPINE 15 MG ODT Generic $0.77 each
MIRTAZAPINE 15 MG TABLET Generic $0.09 each
MIRTAZAPINE 30 MG ODT Generic $0.68 each
MIRTAZAPINE 30 MG TABLET Generic $0.13 each
MIRTAZAPINE 45 MG ODT Generic $0.79 each
MIRTAZAPINE 45 MG TABLET Generic $0.26 each
MIRTAZAPINE 7.5 MG TABLET Generic $1.66 each
remeron (on 6/8/2017 at Medicaid.Gov Pharmacy Drug pricing)
REMERON 15 MG TABLET Generic $0.09 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Mirtazapine (C0049506)

Definition (NCI_NCI-GLOSS) A drug used to treat depression. It belongs to the family of drugs called antidepressant agents.
Definition (NCI) A synthetic tetracyclic derivative of the piperazino-azepines with antidepressant activity. Although its mechanism of action is unknown, mirtazapine enhances central adrenergic and serotonergic transmission, possibly by acting as an antagonist at central presynaptic alpha 2 adrenergic inhibitory autoreceptors and heteroreceptors. This agent is a potent antagonist of 5-hydroxytryptamine type 2 (5-HT2), 5-HT3, and histamine 1 (H1) receptors, and a moderate antagonist of peripheral alpha 1 adrenergic and muscarinic receptors.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C035133
SnomedCT 108430001, 386847004
LNC LP19150-9, MTHU007402
English 6-azamianserin, Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, mirtazapine, MIRTAZAPINE, Mirtazapine, mirtazapine (medication), mirtazapine [Chemical/Ingredient], Mirtazapine (product), Mirtazapine (substance)
Spanish mirtazapina (producto), mirtazapina (sustancia), mirtazapina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Remeron (C0525726)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C035133
English Remeron, zispin, remeron, Zispin, Celltech brand of mirtazapine, Norset, Organon brand of mirtazapine, Remergil
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree